- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06035549
Resilience in East Asian Immigrants for Advance Care Planning Discussions
February 16, 2026 updated by: University of Illinois at Chicago
Development of a Culturally Tailored Digital Resilience-Building Intervention for East Asian Immigrants With Cancer to Facilitate Advance Care Planning Discussions
The purpose of the study is to develop a culturally tailored digital resilience-building intervention to help East Asian immigrants engage in advance care planning discussions with their family caregivers.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Advance care planning (ACP) is a process to facilitate decision-making for future care and document values and preferences.
However, the advance directive completion rates in East Asian Americans are low, which may extend to disparities in end-of-life care, including rates of hospice use and prevalence of unwanted aggressive treatments.
To address this, this study uses information technology to develop a culturally tailored digital resilience-building intervention with and for East Asian immigrants to help them engage in ACP discussions.
There are two aims of this study: (1) Conduct semi-structured interviews with a total of 30 religious leaders to identify the barriers and facilitators associated with discussing ACP and death-related topics with immigrants from China/Taiwan, Japan, and Korea and (2) Develop a culturally tailored digital resilience-building intervention using think-aloud interviews with 27 pairs of East Asian immigrants with cancer and their family caregivers (9 pairs each for immigrants from China/Taiwan, Japan, and Korea).
Study Type
Observational
Enrollment (Estimated)
84
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Li-Ting H. Longcoy
- Phone Number: 312-996-3024
- Email: liting@uic.edu
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60607
- Recruiting
- University of Illinois Chicago
-
Contact:
- Li-Ting H. Longcoy
- Phone Number: 312-996-3024
- Email: liting@uic.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Religious leaders providing spiritual care to Asian Americans/immigrants or Asian Americans/immigrants living with cancer
Description
Inclusion Criteria for Religious Leaders:
- Age ≥ 18 years
- Serving as a chaplain or religious leader at a healthcare setting or religious organization
- Having experience providing pastoral or spiritual care to Chinese, Japanese, and Korean Americans in the US
- Being able to read and respond to questions in English, Mandarin, Cantonese, Japanese, or Korean.
Exclusion criteria: Not willing to provide consent.
Inclusion Criteria for Patients:
- Age ≥ 18 years
- Having a cancer diagnosis
- Likely self-identifying as a Chinese, Japanese, or Korean American/immigrant
- Being able to read and respond to questions in either English, Mandarin, Japanese, Korean, or Chinese dialects, such as Cantonese, Shanghai, Taishanese, or Taiwanese.
Exclusion Criteria for Patients:
- Having cognitive impairment per the Short Portable Mental Status Questionnaire with more than three errors
Inclusion Criteria for Family Caregivers:
- Age ≥ 18 years
- Being able to read and respond to questions in either English, Mandarin, Japanese, Korean, or Chinese dialects, such as Cantonese, Shanghai, Taishanese, or Taiwanese
- Having a family member who is likely to self-identify as a Chinese, Japanese, or Korean American/immigrant and has been diagnosed with cancer
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Culturally Tailored Digital Resilience-Building
The culturally tailored resilience-building materials will be provided to East Asian immigrants with cancer and their family caregivers.
|
The Culturally Tailored Digital Resilience-Building materials include an introduction to advance care planning and resilience skills that specifically address cultural beliefs and barriers.
|
|
Religious leaders
Religious leaders providing spiritual care to Asian Americans
|
Semi-structured interviews with religious leaders who provide spiritual care to Asian Americans/immigrants.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Usability
Time Frame: Immediately at the end of the think-aloud interview
|
Use the System Usability Scale (range: 0-100) to assess the usability of the intervention.
Higher scores indicate greater perceived usability by users.
|
Immediately at the end of the think-aloud interview
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Acceptability
Time Frame: Immediately at the end of the think-aloud interview
|
Use the Acceptability E-scale to assess the acceptability of the intervention.
Scale total scores range from 6 to 30, and higher scores indicate greater acceptance for the proposed intervention.
|
Immediately at the end of the think-aloud interview
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Religious leaders experience
Time Frame: Immediately at the end of the interview
|
An in-depth understanding of religious leaders' perspectives on barriers and facilitators to discussing death-related topics with immigrants from East Asia.
|
Immediately at the end of the interview
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Li-Ting H. Longcoy, University of Illinois Chicago College of Nursing
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 27, 2023
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
June 30, 2026
Study Registration Dates
First Submitted
September 6, 2023
First Submitted That Met QC Criteria
September 6, 2023
First Posted (Actual)
September 13, 2023
Study Record Updates
Last Update Posted (Actual)
February 18, 2026
Last Update Submitted That Met QC Criteria
February 16, 2026
Last Verified
January 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2023-0560
- KC_Awd_114452 (Other Identifier: University of Illinois at Chicago)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neoplasms
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityRecruitingRectal Neoplasms | Colon Neoplasms | Metagenome | MicrobiotaChina
-
European Association for Endoscopic SurgeryWithdrawn
-
Moscow Clinical Scientific CenterRecruitingCecal Neoplasms | Colonic Neoplasms MalignantRussian Federation
-
H. Lee Moffitt Cancer Center and Research InstituteNot yet recruitingPeritoneal CarcinomatosisUnited States
-
Second Affiliated Hospital, School of Medicine,...RecruitingColonic NeoplasmsChina
-
Nanjing Medical UniversityNot yet recruitingMalignant Meningioma
-
Joshua PalmerRayzeBio, Inc.RecruitingRecurrent MeningiomaUnited States
-
Chang Gung Memorial HospitalNational Science and Technology CouncilRecruiting
-
Intergroupe Francophone de Cancerologie ThoraciqueRegeneron PharmaceuticalsNot yet recruiting
-
Royal North Shore HospitalNorthern Sydney and Central Coast Area Health ServiceRecruiting
Clinical Trials on Culturally Tailored Digital Resilience-Building
-
University of Medicine and Dentistry of New JerseyCompletedIrritable Bowel Syndrome | Fibromyalgia | Chronic Fatigue SyndromeUnited States
-
Abramson Cancer Center at Penn MedicineNational Cancer Institute (NCI); Dana-Farber Cancer Institute; Stanford University and other collaboratorsCompletedCigarette Smoking BehaviorUnited States
-
University of Colorado, DenverWashington State University; Missouri Breaks Industries Research, Inc.CompletedAlzheimer DiseaseUnited States
-
University of Alabama at BirminghamCompletedCommunity Dwelling Adults Aged 50 and OlderUnited States
-
University of Missouri, Kansas CityChildren's Mercy Hospital Kansas City; University of Massachusetts, Amherst; University... and other collaboratorsRecruitingPreDiabetes | Overweight and ObesityUnited States
-
Icahn School of Medicine at Mount SinaiRecruitingBurnout, Psychological | Stress, Psychological | Resilience, PsychologicalUnited States
-
University of Illinois at ChicagoNational Institute of Nursing Research (NINR)CompletedResilience, Psychological | Advance Care PlanningUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR)UnknownNovel Model for South Asian Treatment in Diabetes (NaMaSTe-Diabetes) Trial in Primary Care (Namaste)Type 2 Diabetes MellitusCanada
-
Johns Hopkins UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedViolence, Domestic | Violence-Related SymptomUnited States
-
Washington State UniversityOptum, Inc.Completed